azur said:

http://steroid-forums.com/

---

Quote:

We improved medial collateral ligament (MCL) healing throughout 90 days after surgical transection. We introduced intraperitoneal, per-oral (in drinking water) and topical (thin cream layer) peptide therapy always given alone, without a carrier. Previously, as an effective peptide therapy, stable gastric pentadecapeptide BPC 157 (GEPPPGKPADDAGLV, an anti-ulcer peptide effective in inflammatory bowel disease therapy (PL 14736)) particularly improved healing of transected tendon and muscle and wound healing effect including the expression of the early growth response 1 (egr-1) gene. After MCL transection BPC 157 was effective in rats when given once daily intraperitoneally (10 microg or 10 ng/kg) or locally as a thin layer (1.0 microg dissolved in distilled water/g commercial neutral cream) at the site of injury, first application 30 min after surgery and the final application 24 h before sacrifice. Likewise, BPC 157 was effective given per-orally (0.16 microg/ml in the drinking water (12 ml/day/rat)) until sacrifice. Commonly, BPC 157 microg-ng-rats exhibited consistent functional, biomechanical, macroscopic and histological healing improvements. Thus, we suggest BPC 157 improved healing of acute ligament injuries in further ligament therapy.

---

Quote:

BACKGROUND:

There have been few scientific studies that have examined usage of human growth hormone to accelerate recovery from injury. The hypothesis of this study was that human growth hormone would accelerate tendon-to-bone healing compared with control animals treated with placebo in a rat model of acute rotator cuff injury repair.
METHODS:

Seventy-two rats underwent repair of acute rotator cuff injuries and were randomized into the following postoperative dosing regimens: placebo, and human growth hormone at 0.1, 1, 2, 5, and 10 mg/kg/day, administered subcutaneously once per day for fourteen days (Protocol 1). An additional twenty-four rats were randomized to receive either (1) placebo or (2) human growth hormone at 5 mg/kg, administered subcutaneously twice per day for seven days preoperatively and twenty-eight days postoperatively (Protocol 2). All rats were killed twenty-eight days postoperatively. Mechanical testing was performed. Ultimate stress, ultimate force, stiffness, energy to failure, and ultimate distension were determined.
RESULTS:

For Protocol 1, analysis of variance testing showed no significant difference between the groups with regard to ultimate stress, ultimate force, stiffness, energy to failure, or ultimate distension. In Protocol 2, ultimate force to failure was significantly worse in the human growth hormone group compared with the placebo group (21.1 ± 5.85 versus 26.3 ± 5.47 N; p = 0.035). Failure was more likely to occur through the bone than the tendon-bone interface in the human growth hormone group compared with the placebo group (p = 0.001). No significant difference was found for ultimate stress, ultimate force, stiffness, energy to failure, or ultimate distension between the groups in Protocol 2.
CONCLUSIONS:

In this rat model of acute tendon-bone injury repair, daily subcutaneous postoperative human growth hormone treatment for fourteen days failed to demonstrate a significant difference in any biomechanical parameter compared with placebo. Furthermore, subcutaneous administration of 5 mg/kg of human growth hormone twice daily from seven days preoperatively until twenty-eight days postoperatively demonstrated lower loads to ultimate failure and a higher risk of bone fracture failure compared with placebo.

---

Quote:

Trans Resveratrol (50%)

Trans Resveratrol is a natural compound that is found in the skin of red grapes. It has a number of overall health benefits due to its antioxidant properties and is well known for its cardiovascular benefits, but the primary reason for its inclusion in PCT Assist is for its potential to help control estrogen and maximize natural testosterone levels.

Trans Resveratrol works at the receptor level to block estrogen receptors. The benefit there is two fold as it helps eradicate estrogen while also helping to boost natural testosterone production. It is a unique compound in that it has the capability of modulating estrogen receptors as well as controlling aromatase.

Indole-3-Carbinol (I3C)

Indole-3-Carbinol (I3C) is a naturally occurring phytochemical found such vegetables as broccoli and cabbage. It is included in PCT Assist due to its effect on modulating estrogen metabolism. I3C is thought to help increase beneficial estrogen metabolites while decreasing the ‘bad’ estrone metabolites.

Icariin (40%) (Horny Goat Weed)

Icariin is derived from Horny Goat Weed. There are numerous standardizations available, but for the purpose of inclusion in PCT Assist, we selected the ultra potent 40% extract.

Icariin is thought to increase circulating testosterone levels as well as help improve sex drive, making it an excellent addition during the post cycle therapy period. In addition, it is thought that two of the metabolites of icariin may be potent estrogen receptor antagonists, making it even more synergistic with resveratrol.

Mucuna Pruriens SE (Precision Blended 95% & 20% Extracts)

Mucuna Pruriens is an adaptogenic herb that helps increase LH (Luteinizing hormone) which can lead to increases in testosterone production and release. It can also significantly help elevate levels of growth hormone (GH) in the body, and lower prolactin levels by increasing dopamine neurotransmitter synthesis.

Piperine (95%)

Piperine is included in the PCT Assist formula due to its ability to enhance absorption of nutrients and phytochemicals in the intestines. It is also thought to inhibit the glucuronidase enzyme, which is an enzyme that degrades resveratrol.

---